Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Royalty Pharma plc | Director | Class A Ordinary Shares | 1.5M | $41.3M | $27.55 | Jun 30, 2021 | GA RP Holding, L.P. |
Royalty Pharma plc | Director | Class A Ordinary Shares | 540K | $14.9M | $27.55 | Jun 25, 2021 | By Groton Restricted Fund LP |
Royalty Pharma plc | Director | Class A Ordinary Shares | 540K | $14.9M | $27.55 | Jun 30, 2021 | By Madison Park Capital, LLC |
BlackRock Inc. | Director | Common Stock | 16K | $12.2M | $761.86 | Jun 28, 2024 | Direct |
Royalty Pharma plc | Director | Class A Ordinary Shares | 6.6K | $182K | $27.55 | Jun 30, 2021 | Direct |
BlackRock Funding, Inc. /DE | Director | Common Stock | 16K | Sep 30, 2024 | Direct | ||
IHS Markit Ltd. | Director | Common Shares | 0 | $117.47 | Feb 28, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BLK | BlackRock, Inc. | Sep 30, 2024 | 1 | $0 | 4 | Oct 2, 2024 | Director |
BLK | BlackRock Inc. | Jun 28, 2024 | 1 | $0 | 4 | Jul 2, 2024 | Director |
BLK | BlackRock Inc. | Mar 28, 2024 | 1 | $0 | 4 | Apr 1, 2024 | Director |
BLK | BlackRock Inc. | Jan 16, 2024 | 1 | $0 | 4 | Jan 18, 2024 | Director |
BLK | BlackRock Inc. | Dec 29, 2023 | 1 | $0 | 4 | Jan 3, 2024 | Director |
BLK | BlackRock Inc. | Sep 29, 2023 | 1 | $0 | 4 | Oct 3, 2023 | Director |
BLK | BlackRock Inc. | Jun 30, 2023 | 1 | $0 | 4 | Jul 5, 2023 | Director |
BLK | BlackRock Inc. | Mar 31, 2023 | 1 | $0 | 4 | Apr 4, 2023 | Director |
BLK | BlackRock Inc. | Jan 17, 2023 | 1 | $240K | 4 | Jan 19, 2023 | Director |
BLK | BlackRock Inc. | Dec 30, 2022 | 1 | $0 | 4 | Jan 4, 2023 | Director |
BLK | BlackRock Inc. | Sep 30, 2022 | 1 | $0 | 4 | Oct 4, 2022 | Director |
BLK | BlackRock Inc. | Jun 30, 2022 | 1 | $0 | 4 | Jul 1, 2022 | Director |
BLK | BlackRock Inc. | Apr 14, 2022 | 2 | $2.06M | 4 | Apr 18, 2022 | Director |
BLK | BlackRock Inc. | Mar 31, 2022 | 1 | $0 | 4 | Apr 4, 2022 | Director |
INFO | IHS Markit Ltd. | Feb 28, 2022 | 2 | $0 | 4 | Mar 2, 2022 | Director |
BLK | BlackRock Inc. | Jan 18, 2022 | 1 | $240K | 4 | Jan 20, 2022 | Director |
BLK | BlackRock Inc. | Dec 31, 2021 | 1 | $0 | 4 | Jan 4, 2022 | Director |
INFO | IHS Markit Ltd. | Dec 15, 2021 | 1 | $0 | 4 | Dec 17, 2021 | Director |
BLK | BlackRock Inc. | Sep 30, 2021 | 1 | $0 | 4 | Oct 4, 2021 | Director |
INFO | IHS Markit Ltd. | Sep 15, 2021 | 1 | $0 | 4 | Sep 16, 2021 | Director |
BLK | BlackRock Inc. | Jun 30, 2021 | 1 | $0 | 4 | Jul 2, 2021 | Director |
RPRX | Royalty Pharma plc | Jun 30, 2021 | 1 | $37.5K | 4 | Jun 30, 2021 | Director |
RPRX | Royalty Pharma plc | Jun 25, 2021 | 1 | $0 | 4 | Jun 29, 2021 | Director |
INFO | IHS Markit Ltd. | Jun 15, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |
INFO | IHS Markit Ltd. | May 5, 2021 | 1 | $0 | 4 | May 7, 2021 | Director |